Emcure, HDT settle legal fight over COVID vaccine technology
By Blake Brittain(Reuters) - Indian generic drugmaker Emcure Pharmaceuticals and U.S. vaccine developer HDT Bio have settled allegations that Emcure...
By Blake Brittain(Reuters) - Indian generic drugmaker Emcure Pharmaceuticals and U.S. vaccine developer HDT Bio have settled allegations that Emcure...